Advertisement

Anti-inflammatory Effects of Exercise

  • Michael GleesonEmail author
Chapter
Part of the Energy Balance and Cancer book series (EBAC, volume 7)

Abstract

Chronic low-level inflammation is associated with obesity and increased incidence of cancer and chronic disease states. Regular exercise reduces the risk of some cancers as well as chronic metabolic and cardiorespiratory diseases, in part because exercise exerts anti-inflammatory effects. The anti-inflammatory effects of regular exercise may be mediated via both a reduction in visceral fat mass (with a subsequent decreased release of adipokines) and the induction of an anti-inflammatory environment with each bout of exercise via the release of IL-6 from working skeletal muscle, reduced expression of TLRs on monocytes/macrophages, inhibition of monocyte/macrophage infiltration into adipose tissue, phenotypic switching of macrophages within adipose tissue, a reduction in the circulating numbers of pro-inflammatory monocytes and an increase in the circulating numbers of regulatory T cells.

Keywords

Adipose Tissue Exercise Training Muscle Damage Regular Exercise Macrophage Infiltration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H (2004) Walking and dementia in physically capable elderly men. JAMA 292:1447–1453PubMedGoogle Scholar
  2. 2.
    Baeten D, Boots AM, Steenbakkers PG, Elewaut D, Bos E, Verheijden GF, Berheijden G, Miltenburg AM, Rijnders AW, Veys EM, De Keyser F (2000) Human cartilage gp39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 43:1233–1243PubMedGoogle Scholar
  3. 3.
    Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, Cardelli P, Fallucca S, Alessi E, Fallucca F, Pugliese G, Italian Diabetes Exercise Study (IDES) Investigators (2010) Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 170:1794–1803PubMedGoogle Scholar
  4. 4.
    Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13:71–76PubMedGoogle Scholar
  5. 5.
    Bays HE (2009) “Sick fat,” metabolic disease, and atherosclerosis. Am J Med 122:S26–S37PubMedGoogle Scholar
  6. 6.
    Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Grankenberger B, EspeviK T, Ziegler-Heitbrock L (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168:3536–3542PubMedGoogle Scholar
  7. 7.
    Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlböck M, Roth E, Függer R (1999) Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 12:421–427PubMedGoogle Scholar
  8. 8.
    Bianchini F, Kaaks R, Vainio H (2002) Weight control and physical activity in cancer prevention. Obes Rev 3:5–8PubMedGoogle Scholar
  9. 9.
    Bishop NC, Walker GJ, Gleeson M, Wallace FA, Hewitt CRA (2009) Human T lymphocyte migration towards the supernatants of human rhinovirus infected airway epithelial cells: influence of exercise and carbohydrate intake. Exerc Immunol Rev 15:42–59Google Scholar
  10. 10.
    Bosanská L, Michalský D, Lacinová Z, Dostálová I, Bártlová M, Haluzíková D, Matoulek M, Kasalický M, Haluzík M (2010) The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules. Physiol Res 59:79–88PubMedGoogle Scholar
  11. 11.
    Bruun JM, Lihn AS, Pedersen SB, Richelsen B (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90:2282–2289PubMedGoogle Scholar
  12. 12.
    Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, Johansen TL, MacLean DA, Pedersen BK (1997) Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. J Physiol 499:833–841PubMedGoogle Scholar
  13. 13.
    Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH (2005) Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 16:1711–1722PubMedGoogle Scholar
  14. 14.
    Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867PubMedGoogle Scholar
  15. 15.
    Croisier JL, Camus G, Venneman I, Deby-Dupont G, Juchmès-Ferir A, Lamy M, Crielaard JM, Deby C, Duchateau J (1999) Effects of training on exercise-induced muscle damage and interleukin 6 production. Muscle Nerve 22:208–212PubMedGoogle Scholar
  16. 16.
    Cupps TR, Fauci AS (1982) Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133–155PubMedGoogle Scholar
  17. 17.
    Davis JM, Kohut ML, Jackson DA, Colbert LH, Mayer EP, Ghaffar A (1998) Exercise effects on lung tumor metastases and in vitro alveolar macrophage antitumor cytotoxicity. Am J Physiol 274:R1454–R1459PubMedGoogle Scholar
  18. 18.
    Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, Turatti A, Garcia SB (2008) Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis. Med Sci Sports Exerc 40:618–621PubMedGoogle Scholar
  19. 19.
    Eliassen HA, Hankinson SE, Rosner B, Holmes MD, Willet WC (2010) Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med 170:1758–1764PubMedGoogle Scholar
  20. 20.
    Eriksson KF, Lindgärde F (1991) Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 34:891–898PubMedGoogle Scholar
  21. 21.
    Febbraio MA, Pedersen BK (2002) Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16:1335–1347PubMedGoogle Scholar
  22. 22.
    Fernandez MA, Puttur FK, Wang YM, Howden W, Alexander SI, Jones CA (2008) T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J Immunol 180:1556–1564PubMedGoogle Scholar
  23. 23.
    Fingerle-Rowson G, Angstwurm M, Andreesen R, Ziegler-Heitbrock HW (1998) Selective depletion of CD14+CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 112:501–506PubMedGoogle Scholar
  24. 24.
    Fischer CP (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12:6–33PubMedGoogle Scholar
  25. 25.
    Flynn MG, McFarlin BK, Phillips MD, Stewart LK, Timmerman KL (2003) Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women. J Appl Physiol 95:1833–1842PubMedGoogle Scholar
  26. 26.
    Flynn MG, McFarlin BK (2006) Toll-like receptor 4: link to the anti-inflammatory effects of exercise? Exerc Sport Sci Rev 34:176–181PubMedGoogle Scholar
  27. 27.
    Freeman BD, Buchman TG (2001) Interleukin-1 receptor antagonist as therapy for inflammatory disorders. Expert Opin Biol Ther 1:301–308PubMedGoogle Scholar
  28. 28.
    Friedenreich CM, Gregory J, Kopciuk KA, Mackey JR, Courneya KS (2009) Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer 124:1954–1962PubMedGoogle Scholar
  29. 29.
    Galbo H (1983) Hormonal and metabolic adaptation to exercise. Thieme-Stratton, New YorkGoogle Scholar
  30. 30.
    Gill JMR, Cooper AR (2008) Physical activity and prevention of type 2 diabetes mellitus. Sports Med 38:807–824PubMedGoogle Scholar
  31. 31.
    Gleeson M (2005) Immune function in sport and exercise. Elsevier, EdinburghGoogle Scholar
  32. 32.
    Gleeson M, Bishop NC, Oliveira M, McCauley T, Tauler P, Muhamad AS (2012) Respiratory infection risk in athletes: association with antigen-stimulated IL-10 production and salivary IgA secretion. Scand J Med Sci Sports 22:410–417PubMedGoogle Scholar
  33. 33.
    Gleeson M, McFarlin BK, Flynn MG (2006) Exercise and toll-like receptors. Exerc Immunol Rev 12:34–53PubMedGoogle Scholar
  34. 34.
    Guilietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C (2007) Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77:47–57Google Scholar
  35. 35.
    Haffner SM (2007) Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 120:S10–S16PubMedGoogle Scholar
  36. 36.
    Hardman AE, Stensel DJ (2009) Physical activity and health: the evidence explained, 2nd edn. Routledge, Oxford, pp 120–121Google Scholar
  37. 37.
    Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA, Kim JK (2009) Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 58:2525–2535PubMedGoogle Scholar
  38. 38.
    Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I, Yan W, Xu H (2009) Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58:104–115PubMedGoogle Scholar
  39. 39.
    Ju J, Nolan B, Cheh M, Bose M, Lin Y, Wagner GC, Yang CS (2008) Voluntary exercise inhibits intestinal tumorigenesis in Apc(Min/+) mice and azoxymethane/dextran sulfate sodium-treated mice. BMC Cancer 8:316PubMedGoogle Scholar
  40. 40.
    Kaisho T, Akira S (2006) Toll-like receptor function and signalling. J Allergy Clin Immunol 117:979–987PubMedGoogle Scholar
  41. 41.
    Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494–1505PubMedGoogle Scholar
  42. 42.
    Kasapis C, Thompson PD (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 45:1563–1569PubMedGoogle Scholar
  43. 43.
    Kawanishi N, Yano H, Yokogawa Y, Suzuki K (2010) Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev 16:105–118PubMedGoogle Scholar
  44. 44.
    Keller C, Steensberg A, Hansen AK, Fischer CP, Plomgaard P, Pedersen BK (2005) Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol 99:2075–2079PubMedGoogle Scholar
  45. 45.
    Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29:726–732PubMedGoogle Scholar
  46. 46.
    Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347:1483–1492PubMedGoogle Scholar
  47. 47.
    Lancaster GI, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT, Gleeson M (2005) The physiological regulation of toll-like receptor expression and function in humans. J Physiol 563:945–955PubMedGoogle Scholar
  48. 48.
    Maffei M, Funicello M, Vottari T, Gamucci O, Costa M, Lisi S, Viegi A, Ciampi O, Bardi G, Vitti P, Pinchera A, Santini F (2009) The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2). BMC Biol 17:87Google Scholar
  49. 49.
    Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453–461PubMedGoogle Scholar
  50. 50.
    Mathis D, Shoelson S (2011) Immunometabolism: an emerging frontier. Nat Rev Immunol 11:81PubMedGoogle Scholar
  51. 51.
    Matthews CE, Ockene IS, Freedson PS, Rosal MC, Merriam PA, Hebert JR (2002) Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc 34:1242–1248PubMedGoogle Scholar
  52. 52.
    Maynard CL, Weaver CT (2008) Diversity in the contribution of IL-10 to cell-mediated immune regulation. Immunol Rev 226:219–233PubMedGoogle Scholar
  53. 53.
    McFarlin BK, Flynn MG, Campbell WW, Stewart LK, Timmerman KL (2004) TLR4 is lower in resistance-trained older women and related to inflammatory cytokines. Med Sci Sports Exerc 36:1876–1883PubMedGoogle Scholar
  54. 54.
    Meckel Y, Eliakim A, Seraev M, Zaldivar F, Cooper DM, Sagiv M, Nemet D (2009) The effect of a brief sprint interval exercise on growth factors and inflammatory mediators. J Strength Cond Res 23:225–230PubMedGoogle Scholar
  55. 55.
    Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24:3535–3541PubMedGoogle Scholar
  56. 56.
    Miyashita M, Burns SF, Stensel DJ (2008) Accumulating short bouts of brisk walking reduces postprandial plasma triacylglycerol concentrations and resting blood pressure in healthy young men. Am J Clin Nutr 88:1225–1231PubMedGoogle Scholar
  57. 57.
    Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the ­interleukin-10 receptor. Annu Rev Immunol 19:683–765PubMedGoogle Scholar
  58. 58.
    Nehlsen-Cannarella SL, Fagoaga OR, Nieman DC, Henson DA, Butterworth DE, Schmitt RL, Bailey EM, Warren BJ, Utter A, Davis JM (1997) Carbohydrate and the cytokine response to 2.5 h of running. J Appl Physiol 82:1662–1667PubMedGoogle Scholar
  59. 59.
    Nieman DC, Henson DA, Austin MD, Sha W (2011) Upper respiratory tract infection is reduced in physically fit and active adults. Br J Sports Med 45:987–992PubMedGoogle Scholar
  60. 60.
    Northoff H, Berg A (1991) Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med 12:S9–S15PubMedGoogle Scholar
  61. 61.
    Oliveira M, Gleeson M (2010) The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur J Appl Physiol 109:251–257PubMedGoogle Scholar
  62. 62.
    Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, Pedersen BK (1998) A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 513:889–894PubMedGoogle Scholar
  63. 63.
    Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK (1999) Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515:287–291PubMedGoogle Scholar
  64. 64.
    Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK (2001) Chemokines are elevated in plasma after strenuous exercise in humans. Eur J Appl Physiol 84:244–245PubMedGoogle Scholar
  65. 65.
    Ouchi N, Parker JL, Lugus JJ, Walsk K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97PubMedGoogle Scholar
  66. 66.
    Pedersen BK, Edward F (2009) Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 107:1006–1014PubMedGoogle Scholar
  67. 67.
    Pedersen BK, Fischer CP (2007) Beneficial health effects of exercise–the role of IL-6 as a myokine. Trends Pharmacol Sci 28:152–156PubMedGoogle Scholar
  68. 68.
    Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80:1055–1081PubMedGoogle Scholar
  69. 69.
    Pedersen BK, Saltin B (2006) Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16:S5–S65Google Scholar
  70. 70.
    Petersen AM, Pedersen BK (2005) The anti-inflammatory effect of exercise. J Appl Physiol 98:1154–1162PubMedGoogle Scholar
  71. 71.
    Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjønneland A, Halkjaer J, Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, May AM, Bueno-de-Mesquita HB, van Duijnhoven FJ, Hallmans G, Weinehall L, Manjer J, Hedblad B, Lund E, Agudo A, Arriola L, Barricarte A, Navarro C, Martinez C, Quirós JR, Key T, Bingham S, Khaw KT, Boffetta P, Jenab M, Ferrari P, Riboli E (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105–2120PubMedGoogle Scholar
  72. 72.
    Poitou C, Dalmas E, Renovato M, Benhamo V, Hajduch F, Abdennour M, Kahn JF, Veyrie N, Rizkalla S, Fridman WH, Sautès-Fridman C, Clément K, Cremer I (2011) CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 31:2322–2330PubMedGoogle Scholar
  73. 73.
    Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334PubMedGoogle Scholar
  74. 74.
    Puglisi MJ, Fernandez ML (2008) Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 138:2293–2296PubMedGoogle Scholar
  75. 75.
    Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM (2011) Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urological research endeavor. Cancer Res 71:3889–3895PubMedGoogle Scholar
  76. 76.
    Rose-John S, Scheller J, Elson G, Jones SA (2006) IL-6 biology is co-ordinated by membrane bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80:227–236PubMedGoogle Scholar
  77. 77.
    Ross R, Bradshaw AJ (2009) The future of obesity reduction: beyond weight loss. Nat Rev Endocrinol 5:319–325PubMedGoogle Scholar
  78. 78.
    Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345–352PubMedGoogle Scholar
  79. 79.
    Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, Lackner KJ, Iz M, Meyer J, Darius H, Rupprecht HJ (2004) CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92:419–424PubMedGoogle Scholar
  80. 80.
    Simpson RJ, McFarlin BK, McSporran C, Spielmann G, ó Hartaigh B, Guy K (2009) Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans. Brain Behav Immun 23:232–239PubMedGoogle Scholar
  81. 81.
    Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K (2005) Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin Exp Immunol 141:270–278PubMedGoogle Scholar
  82. 82.
    Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4:87–100PubMedGoogle Scholar
  83. 83.
    Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK (2003) Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 17:884–886PubMedGoogle Scholar
  84. 84.
    Starkie RL, Angus DJ, Rolland J, Hargreaves M, Febbraio MA (2000) Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans. J Physiol 528:647–655PubMedGoogle Scholar
  85. 85.
    Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, Febbraio MA (2001) Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533:585–591PubMedGoogle Scholar
  86. 86.
    Starkie RL, Rolland J, Angus DJ, Anderson MJ, Febbraio MA (2001) Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. Am J Physiol 280:C769–C774Google Scholar
  87. 87.
    Steensberg A (2003) The role of IL-6 in exercise-induced immune changes and metabolism. Exerc Immunol Rev 9:40–47PubMedGoogle Scholar
  88. 88.
    Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:E433–E437PubMedGoogle Scholar
  89. 89.
    Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK (2000) Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529:237–242PubMedGoogle Scholar
  90. 90.
    Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, McFarlin BK, Timmerman KL, Coen PM, Felker J, Talbert E (2005) Influence of exercise training and age on CD14+ cell surface expression of toll-like receptor 2 and 4. Brain Behav Immun 19:389–397PubMedGoogle Scholar
  91. 91.
    Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K (2002) Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 8:6–48PubMedGoogle Scholar
  92. 92.
    Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, Okamura N, Kumae T, Umeda T, Sugawara K (2003) Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc 35:348–355PubMedGoogle Scholar
  93. 93.
    Takeda K, Kaisho T, Akira SS (2003) Toll-like receptors. Annu Rev Immunol 21:335–376PubMedGoogle Scholar
  94. 94.
    Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB (2002) Exercise type and intensity in relation to coronary heart disease in men. JAMA 288:1994–2000PubMedGoogle Scholar
  95. 95.
    Timmerman KL, Flynn MG, Coen PM, Markofski MM, Pence BD (2008) Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol 84:1271–1278PubMedGoogle Scholar
  96. 96.
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedGoogle Scholar
  97. 97.
    Ullum H, Haahour PM, Diamant M, Palmø J, Halkjaer-Kristensen J, Pedersen BK (1994) Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. J Appl Physiol 77:93–97PubMedGoogle Scholar
  98. 98.
    Wang J, Song H, Tang X, Yang Y, Niu Y, Ma Y (2012) Effect of exercise training intensity on murine T-regulatory cells and vaccination response. Scand J Med Sci Sports 22:643–652Google Scholar
  99. 99.
    Warren TY, Barry V, Hooker SP, Sui X, Church TS, Blair SN (2010) Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc 42:879–885PubMedGoogle Scholar
  100. 100.
    West-Wright CN, Henderson KD, Sullivan-Halley J, Ursin G, Deapen D, Neuhausen S, Reynolds P, Chang E, Ma H, Bernstein L (2009) Long-term and recent recreational physical activity and survival after breast cancer: the California Teachers Study. Cancer Epidemiol Biomarkers Prev 18:2851–2859PubMedGoogle Scholar
  101. 101.
    Wetmore CM, Ulrich CM (2004) Mechanisms associating physical activity with cancer incidence: exercise and immune function. CRC Taylor Francis, Boca RatonGoogle Scholar
  102. 102.
    Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71:1057–1064PubMedGoogle Scholar
  103. 103.
    Wolin KY, Yan Y, Colditz GA (2011) Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 104:882–885PubMedGoogle Scholar
  104. 104.
    World Cancer Research Fund (2007) Food, nutrition and the prevention of cancer: a global perspective. WCRF, LondonGoogle Scholar
  105. 105.
    Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:S823–S835PubMedGoogle Scholar
  106. 106.
    Yeh SH, Chuang H, Lin LW, Hsiao CY, Wang PW, Liu RT, Yang KD (2009) Regular Tai Chi Chuan exercise improves T cell helper function of patients with type 2 diabetes mellitus with an increase in T-bet transcription factor and IL-12 production. Br J Sports Med 43:845–850PubMedGoogle Scholar
  107. 107.
    Yeh SH, Chuang H, Lin LW, Hsiao CY, Eng HL (2006) Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells. Br J Sports Med 40:239–243PubMedGoogle Scholar
  108. 108.
    Yudkin JS (2007) Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 39:707–709PubMedGoogle Scholar
  109. 109.
    Zeyda M, Huber J, Prager G, Stulnig TM (2011) Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity 19:743–748PubMedGoogle Scholar
  110. 110.
    Zoppini G, Targher G, Zamboni C, Venturi C, Cacciatori V, Moghetti P, Muggeo M (2006) Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 16:543–549PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.School of Sport, Exercise and Health SciencesLoughborough University, LoughboroughLeicestershireUK

Personalised recommendations